Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pricing
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
congress
drug prices
merck
pbms
pharmacy benefit managers
2019
abbvie
abeona therapeutics
activism
acute hepatic porphyria
What
bio
drug
pharmaceutical
roundup
advanced
alnylam’s
american
approval
away
based
best
bff
bringing
ceos
conference
continue
crash
dc
deals
debate
devoted
disease
easl
executives
form
gathered
gene
groups
healthcare
hearing
held
industry
kicked
kind
liver
lower
major
nash
people
pharma
Language
Current search:
pricing
×
sanofi
×
biotech
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More